MedXCell Revenue and Competitors
Estimated Revenue & Valuation
- MedXCell's estimated annual revenue is currently $2.6M per year.
- MedXCell's estimated revenue per employee is $155,000
Employee Data
- MedXCell has 17 Employees.
- MedXCell grew their employee count by 6% last year.
MedXCell's People
Name | Title | Email/Phone |
---|
MedXCell Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $31.6M | 117 | 15% | N/A | N/A |
#2 | $15640M | 246141 | N/A | N/A | $109.8B |
What Is MedXCell?
MedXCell SA is a Swiss specialist healthcare group with clinical-stage projects. It is dedicated to transforming healthcare through the development and production of affordable and accessible new therapies utilizing the unique healing powers of living cells. MedXCell is devoted to the development and the manufacturing of innovative off-the-shelf cellular therapies offering state-of-the-art, cost-effective and safe solutions for a wide range of patient needs. The company enjoys a close relationship with academic research, most notably with the Institute for Regenerative Medicine and Biotherapy of Montpellier, France.
keywords:N/AN/A
Total Funding
17
Number of Employees
$2.6M
Revenue (est)
6%
Employee Growth %
N/A
Valuation
N/A
Accelerator
MedXCell News
... MedXCell; MiNK Therapeutics; Phio Pharmaceuticals; Biohaven Pharmaceuticals; Lava therapeutics; Allogene Therapeutics/Notch Therapeutics...
Cartron reports personal fees from Roche, BMS-Celgene, Abbvie, Takeda, MedxCell, MabQi, Jansen, Gilead, and Novartis outside the submitted work.
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $7M | 40 | 29% | N/A |
#2 | $7.9M | 53 | -2% | N/A |
#3 | $19.6M | 77 | 7% | N/A |
#4 | $18.7M | 104 | 5% | N/A |